NCT02118428View on ClinicalTrials.gov

Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria

NACompletedINTERVENTIONAL

Enrollment

227

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Malaria

Interventions

DEVICE

Mirasol-treated Whole Blood

Transfusion with fresh Whole Blood treated with the Mirasol Pathogen Reduction Technology System for Whole Blood

BIOLOGICAL

Untreated Whole Blood

Transfusion with untreated fresh Whole Blood

Trial Locations (1)

Unknown

Komfo Anokye Teaching Hospital, Kumasi

All Listed Sponsors

lead

Terumo BCTbio

INDUSTRY

NCT02118428 - Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria | Biotech Hunter | Biotech Hunter